NASIR GEBI: Open Payments
NPI 1861968612 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 13 payments from 6 companies in 2025. Trend: 2023 $441 · 2024 $185 · 2025 $1,089
Honoraria: $750Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| Alpha Cognition USA, Inc. | 1 | $750 |
| Vanda Pharmaceuticals Inc. | 1 | $121 |
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| ACADIA Pharmaceuticals Inc | 4 | $79 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| PROTEGA PHARMACEUTIALS INC | 1 | $24 |
Products named: Zunveyl, FANAPT, REXULTI, NUPLAZID, INGREZZA, ROXYBOND.
Industry payments across WA — which companies pay providers there.
